MELVIN MD SHAROKY

CIK 1182633 · last filed 2026-05-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$24.75M

Companies

2

Total Filings

78

Lifetime Open-Market Net

-$7.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INSM Director 252,928 $97.85 $24.75M -$7.64M 52 2026-05-15
PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted Director 5,890 -$203.1K 25 2012-07-05

Recent Filings · Page 4 of 8

78 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-09-07 INSM Sell (S) −50,000 -$1.37M EDGAR
2017-05-19 INSM Grant (A) +6,702 $0 EDGAR
2016-05-23 INSM Grant (A) +12,742 $0 EDGAR
2015-03-26 INSM Exer (M) +1,750 $11.4K EDGAR
2015-01-09 INSM Grant (A) +6,222 $0 EDGAR
2014-08-14 INSM Buy (P) +88,889 $1.00M EDGAR
2014-01-14 INSM Mixed +11,883 $0 EDGAR
2013-01-15 INSM Mixed +10,174 $0 EDGAR
2012-10-02 Disp (D) $0
2012-07-05 PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted Grant (A) $0 EDGAR
Showing 3140 of 78
Page 4 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.